RLS Global, and ConvaTec have made continued progress with the distribution and commercialisation of ChloraSolv® in Europe. After intensive market preparation and work with specialist wound experts in the Netherlands, ChloraSolv® gel was listed on January 1, 2022 in the Z- index and received a positive recommendation for reimbursement from Zorginstituut Nederland (ZN). Chlorasolv® is already available in other European markets such as the Nordic countries.
1st Jan change | Capi. | |
---|---|---|
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.68% | 238B | |
+7.01% | 204B | |
-6.18% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |